Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Business

South Korea's Celltrion gets UK approval for trials of COVID-19 antibody drug

FILE PHOTO: The logo of Celltrion is seen at the company's headquarters in Incheon, South Korea, October 28, 2016. REUTERS/Kim Hong-Ji

South Korea's Celltrion Inc on Thursday said British regulators had given it regulatory approval for a phase I clinical trial of its experimental COVID-19 treatment drug.

The company will enrol participants for a clinical study in the UK after approval from the Medicines and Healthcare Products Regulatory Agency (MHRA), Celltrion said in a statement.

South Korean regulators on July 17 approved an early stage clinical trial for the drug, making it the country's first such antibody drug to be tested on humans.

(Reporting by Sangmi Cha; Editing by Tom Hogue)

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.